semaglutide news today october 2025 Obesity drugs improve health but may not reduce overall health care costs FDA Decisions Expected: October 2025

Younger consumers, particularly in markets such as the U.S

Semaglutide and other GLP-1 medications are controlled prescription drugs that the FDA reserves for medical supervision because they lower blood sugar and reduce appetite through specific mechanisms in your brain and gut

L-carnitine is often marketed as a fat-burning supplement because it helps metabolise fatty acids

This means that the FDA has not verified their safety, effectiveness, or quality

Interestingly, glycine treatment significantly reduced the plasma concentrations of alanine transaminase and aspartate transaminase but had no significant effects on albumin, alkaline phosphatase, or gamma-glutamyl transferase plasma concentrations